Amytracker - Publications
Amytracker visualizes Aβ aggregates in Alzheime...
Brain organoids are self-assembled three-dimensional aggregates generated from pluripotent stem cells. They offer a reproducible, optimized platform filling in the gap that traditional models for neurodegenerative diseases struggle to address....
Amytracker visualizes Aβ aggregates in Alzheime...
Brain organoids are self-assembled three-dimensional aggregates generated from pluripotent stem cells. They offer a reproducible, optimized platform filling in the gap that traditional models for neurodegenerative diseases struggle to address....
Amytracker for staining recombinant Spider Silk...
Biomaterials composed of self-assembling protein building blocks are being actively explored for biomedical applications, including drug delivery, tissue engineering scaffolds, and functionalized surface coatings. Among these, spider silk has attracted...
Amytracker for staining recombinant Spider Silk...
Biomaterials composed of self-assembling protein building blocks are being actively explored for biomedical applications, including drug delivery, tissue engineering scaffolds, and functionalized surface coatings. Among these, spider silk has attracted...
Tracing Tau: A Step Closer to Understanding Neu...
Tauopathies, including Alzheimer's disease (AD) and Pick’s disease, are characterized by the aggregation of tau proteins into insoluble filaments. Traditional cell-based assays modelling tau seeding often rely on mutant or...
Tracing Tau: A Step Closer to Understanding Neu...
Tauopathies, including Alzheimer's disease (AD) and Pick’s disease, are characterized by the aggregation of tau proteins into insoluble filaments. Traditional cell-based assays modelling tau seeding often rely on mutant or...
Finding the Invisible: How Amyloid Detection Is...
Neurodegenerative diseases, such as Parkinson’s, often begin decades before clinical symptoms are observed. Early detection is crucial, but identifying disease biomarkers - like the low concentrations of α-synuclein aggregates -...
Finding the Invisible: How Amyloid Detection Is...
Neurodegenerative diseases, such as Parkinson’s, often begin decades before clinical symptoms are observed. Early detection is crucial, but identifying disease biomarkers - like the low concentrations of α-synuclein aggregates -...
Glycosylation guides a safer strain of α-synuclein
Aggregated α-synuclein is part of the pathology of Parkinson’s disease and dementia with Lewy bodies, but why these oligomeres and fibrils aggregate as part of these diseases - or how...
Glycosylation guides a safer strain of α-synuclein
Aggregated α-synuclein is part of the pathology of Parkinson’s disease and dementia with Lewy bodies, but why these oligomeres and fibrils aggregate as part of these diseases - or how...
ApoE Aggregates and Innate Immunity: Insights i...
Apolipoprotein E (ApoE) is widely recognized as a key genetic risk factor for Alzheimer’s disease.It is also implicated in other protein aggregation disorders such as Parkinson’s disease and Lewy Body...
ApoE Aggregates and Innate Immunity: Insights i...
Apolipoprotein E (ApoE) is widely recognized as a key genetic risk factor for Alzheimer’s disease.It is also implicated in other protein aggregation disorders such as Parkinson’s disease and Lewy Body...